Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Uslaner

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJonathan A Sugam, Seth Robey, Sokreine Suon, et al.
Neuropharmacology|July 4, 2012
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkeySean M Smith, Jason M Uslaner, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2018
Indole acids as a novel PDE2 inhibitor chemotype that demonstrate pro-cognitive activity in multiple speciesShawn J Stachel, Melissa S Egbertson, Jenny Wai, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosisMark E Layton, Alexander J Reif, Timothy J Hartingh, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2010
3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead effortsEdward J Brnardic, Mark E Fraley, Robert M Garbaccio, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDIJoseph E Pero, Michael A Rossi, Michael J Kelly, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2008
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serineSean M Smith, Jason M Uslaner, Lihang Yao, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentJonathan A Sugam, Seth Robey, Sokreine Suon, et al.
Neuropharmacology|July 4, 2012
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkeySean M Smith, Jason M Uslaner, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2018
Indole acids as a novel PDE2 inhibitor chemotype that demonstrate pro-cognitive activity in multiple speciesShawn J Stachel, Melissa S Egbertson, Jenny Wai, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosisMark E Layton, Alexander J Reif, Timothy J Hartingh, et al.
Neuropharmacology|July 15, 2009
Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposureChristopher J Winrow, Keith Q Tanis, Duane R Reiss, et al.
Frontiers in Neuroscience|January 9, 2014
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulatorsAndres D Ramirez, Anthony L Gotter, Steven V Fox, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2010
3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead effortsEdward J Brnardic, Mark E Fraley, Robert M Garbaccio, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDIJoseph E Pero, Michael A Rossi, Michael J Kelly, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2008
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serineSean M Smith, Jason M Uslaner, Lihang Yao, et al.
Pageof 8